Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...

While competitors like Eli Lilly and Novo Nordisk race to capture the booming weight-loss drug market, Novartis is steering ...

GOOGL), has announced two separate research collaborations with Eli Lilly (LLY) and Novartis (NVS). The deal with Eli Lilly (LLY) marks its first pharmaceutical partnership, the London-based ...

As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

Novartis’ Vas Narasimhan, and Eli Lilly’s David Ricks backed the proposals to end rebates paid to pharmacy benefit managers and health insurers that push up the prices of their diabetes medicines.

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

announcing its first pharma partnerships with Eli Lilly and Novartis, worth almost $3 billion. The company – led by Google DeepMind Founder Demis Hassabis and formed just over two years ago ...

Recent health industry updates reveal Sun Pharma's profit surge due to specialty drugs, Pfizer's strategic focus under ...

Bearing that in mind, we used TipRanks’ Stock Comparison Tool to place Eli Lilly (LLY), Novartis (NVS), and Intuitive Surgical (ISRG) against each other to find the healthcare stock with a ...

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

Researchers from organizations with new access to Truveta Data include American Heart Association, Bayer, Edwards Lifesciences, Eli Lilly and Co., Gates Ventures, GORE, Impulse Dynamics, Indiana ...